GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Templates Inc (OTCPK:MTEM) » Definitions » Shiller PE Ratio

MTEM (Molecular Templates) Shiller PE Ratio : (As of Apr. 26, 2025)


View and export this data going back to 2005. Start your Free Trial

What is Molecular Templates Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Molecular Templates Shiller PE Ratio Historical Data

The historical data trend for Molecular Templates's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Templates Shiller PE Ratio Chart

Molecular Templates Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Molecular Templates Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Molecular Templates's Shiller PE Ratio

For the Biotechnology subindustry, Molecular Templates's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molecular Templates's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Templates's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Molecular Templates's Shiller PE Ratio falls into.


;
;

Molecular Templates Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Molecular Templates's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Molecular Templates's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-1.23/132.5538*132.5538
=-1.230

Current CPI (Jun. 2024) = 132.5538.

Molecular Templates Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 -24.750 100.428 -32.667
201412 -19.800 99.070 -26.492
201503 -28.050 99.621 -37.323
201506 -19.800 100.684 -26.067
201509 -14.850 100.392 -19.607
201512 141.900 99.792 188.485
201603 -18.150 100.470 -23.946
201606 -16.500 101.688 -21.508
201609 -13.200 101.861 -17.177
201612 -8.250 101.863 -10.736
201703 -11.550 102.862 -14.884
201706 3.300 103.349 4.233
201709 -9.300 104.136 -11.838
201712 -3.900 104.011 -4.970
201803 -4.800 105.290 -6.043
201806 -5.400 106.317 -6.733
201809 -2.850 106.507 -3.547
201812 -2.700 105.998 -3.376
201903 -2.550 107.251 -3.152
201906 -3.750 108.070 -4.600
201909 -15.450 108.329 -18.905
201912 -6.150 108.420 -7.519
202003 -7.200 108.902 -8.764
202006 -10.200 108.767 -12.431
202009 -7.050 109.815 -8.510
202012 -8.550 109.897 -10.313
202103 -7.650 111.754 -9.074
202106 -4.200 114.631 -4.857
202109 -8.100 115.734 -9.277
202112 -2.700 117.630 -3.043
202203 -5.700 121.301 -6.229
202206 -6.450 125.017 -6.839
202209 -6.560 125.227 -6.944
202212 -5.850 125.222 -6.193
202303 2.890 127.348 3.008
202306 -2.890 128.729 -2.976
202309 -0.820 129.860 -0.837
202312 -0.810 129.419 -0.830
202403 0.080 131.776 0.080
202406 -1.230 132.554 -1.230

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Molecular Templates  (OTCPK:MTEM) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Molecular Templates Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Molecular Templates's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecular Templates Business Description

Traded in Other Exchanges
N/A
Address
9301 Amberglen Boulevard, Suite 100, Austin, TX, USA, 78729
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
Executives
Biotech Target N V 10 percent owner ARA HILL TOP BUILDING, UNIT A-5, PLETTERIJWEG OOST 1, CURACAO, WILLEMSTAD P8 000000
Maurizio Voi officer: Chief Medical Officer 4 MAGUIRE ROAD, LEXINGTON MA 02421
Sean Mclennan officer: CFO & Treasurer C/O MOLECULAR TEMPLATES, INC., 93010 AMBERGLEN BLVD., SUITE 100, AUSTIN TX 78729
Kevin M. Lalande director, 10 percent owner 201 WEST 5TH STREET, AUSTIN TX 78701
Shv Management Services, Llc 10 percent owner FROST TOWER, 401 CONGRESS AVENUE, SUITE 2950, AUSTIN TX 78701
Gabriela Gruia director C/O TSCAN THERAPEUTICS, INC., 830 WINTER STREET, WALTHAM MA 02451
Jason S. Kim officer: See Remarks 9301 AMBERGLEN BOULEVARD, SUITE 100, C/O MOLECULAR TEMPLATES, INC., AUSTIN TX 78729
Biotech Ag Bb 10 percent owner SCHWERTSTRASSE 6, SCHAFFHAUSEN V8 8200
Longitude Capital Partners Iii, Llc 10 percent owner 800 EL CAMINO, SUITE 220, MENLO PARK CA 94025
Sanders Corazon (corsee) D. director C/O MOLECULAR TEMPLATES, INC., 9301 AMBERGLEN BLVD, SUITE 100, AUSTIN VI 78729
Patrick G Enright 10 percent owner CO LONGITUDE CAPITAL PARTNERS LLC, 800 EL CAMINO REAL, SUITE 220, MENLO PARK CA 94025
Bakker Juliet Tammenoms 10 percent owner LONGITUDE CAPITAL MANAGEMENT CO., LLC, 800 EL CAMINO REAL, SUITE 220, MENLO PARK CA 94025
David Hirsch director, 10 percent owner C/O LONGITUDE CAPITAL PARTNERS, LLC, 800 EL CAMINO REAL, SUITE 220, MENLO PARK CA 94025
Longitude Venture Partners Iii, L.p. 10 percent owner 800 EL CAMINO REAL, SUITE 220, MENLO PARK CA 94025
Scott D Morenstein director C/O CAXTON ALTERNATIVE MANAGEMENT LP, 1330 SIXTH AVENUE, 20TH FLOOR, NEW YORK NY 10019